GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                             Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: YCT529 is an oral retinoic acid receptor alpha (RAR-α) antagonist, that is being investigated as a non-hormonal male contraceptive. Its development and function were presented at the spring meeting of the American Chemical Society (ACS) in March 2022. Antagonising RAR-α disrupts spermatogenesis. YCT529 is formulated as a sodium salt. The RAR-α-selective antagonists BMS-189532 and BMS-189614 have been reported previously [1-2].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Chung SS, Cuellar RA, Wang X, Reczek PR, Georg GI, Wolgemuth DJ. (2013)
                                         Pharmacological activity of retinoic acid receptor alpha-selective antagonists in vitro and in vivo.. ACS Med Chem Lett, 4 (5): 446-450. [PMID:24040487]  | 
                                                                
| 
                                                                         2. Noman MAA, Kyzer JL, Chung SSW, Wolgemuth DJ, Georg GI. (2020)
                                         Retinoic acid receptor antagonists for male contraception: current status†. Biol Reprod, 103 (2): 390-399. [PMID:32671394]  |